COLORADO RESEARCH PARTNERS, LLC
Biotech · Private
Small-molecule therapeutic that blocks fructokinase C (KHK-C) enzyme to inhibit fructose metabolism
- Grants
- $1.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 1 granted · 0 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Scientific Merit and Feasibility of Fructokinase Inhibiton for Obesity | $183,693 | |
| Federal grant | Department of Health and Human Services · Phase II · Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | $289,373 | |
| Federal grant | Department of Health and Human Services · Phase II · Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | $769,627 | |
| Federal grant | Department of Health and Human Services · Phase II · Scientific Merit and Feasibility of Fructokinase Inhibition for Obesity | $206,585 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2396 | NeuvaRx, LLC | — | — |
| 2397 | Antiva Biosciences | — | $81M |
| 2398 | Fate Therapeutics | — | $236M |
| 2399 | COLORADO RESEARCH PARTNERS, LLC | — | — |
| 2400 | Halda Therapeutics | — | $198M |
| 2401 | MCM6 THERAPEUTICS, INC. | — | — |
| 2402 | IZON Technologies, LLC | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.